Microbot Medical Stock Gains Nearly 15% Following LIBERTY Trial Data Presentation

(RTTNews) - Microbot Medical Inc. (MBOT) jumped 14.75 percent to $1.60 during Wednesday's trading after presenting pivotal trial data for its LIBERTY Endovascular Robotic System at the Society of Interventional Radiology annual meeting.

The stock opened at $1.79 and has traded between $1.48 and $2.11 so far today, up from a previous close of $1.39 on the Nasdaq. Volume surged to 31.3 million shares, well above the average of 2.38 million. MBOT is trading in the upper half of its 52-week range of $0.82 to $3.38.

The ACCESS-PVI study, conducted at top U.S. medical centers including Memorial Sloan Kettering and Brigham and Women's Hospital, was highlighted during a late-breaking podium session by Dr. Francois Cornelis of Memorial Sloan Kettering.